AD Indication definition

AD Indication means atopic dermatitis.
View Source
AD Indication means any Alzheimer’s disease (AD) Indication listed under the header “INDICATIONS AND USAGE” of a Product’s approved label upon Regulatory Approval for the Product by a Regulatory Authority, including any patient group, population or subpopulation, including but not limited to an indication for preclinical or asymptomatic at risk, prodromal or mild cognitive impairment due to AD, mild, moderate or severe AD, familial AD, AD with mixed pathology or mixed AD with cardiovascular dementia.
View Source
AD Indication means the treatment of atopic dermatitis without any Black Box Warnings.
View Source

Examples of AD Indication in a sentence

  • Upon the occurrence of Marketing Approval Revocation/Withdrawal applicable to the AD Indication, the total number of quarterly AD Milestone Payments due under this Section 4.1(a)(i)(1) (AD Payments) shall be reduced to the number of AD Milestone Payments received by NovaQuest as of the date of such Marketing Approval Revocation/Withdrawal.

  • If ACI thereafter solely Develops a Product for a Second Indication (and not in collaboration with a Third Party), and provided that such Product shall not contain [*****] as the Product ▇▇▇▇▇▇▇ is Developing for the AD Indication, then ACI will give written notice to ▇▇▇▇▇▇▇ upon completion of a phase 2b Clinical Trial for such Second Indication of the Product and ▇▇▇▇▇ ▇▇▇▇▇▇▇ the exclusive right to negotiate an agreement to Develop and Commercialize the Product for the Second Indication.

  • For clarity, Dermavant shall pay NovaQuest [***] Psoriasis Milestone Payments if there is no termination of the Program solely with respect to the AD Indication or Dermavant shall pay NovaQuest [***] Psoriasis Milestone Payments if there is a termination of the Program solely with respect to the AD Indication and due to an event other than for a [***].

  • For example, for a Phase Ib/IIa trial in the AD Indication or Second Indication, initiation of the Phase IIa portion of the trial shall be considered achievement of the “Phase II Initiation Milestone (AD)” or the “Phase II Initiation Milestone (Second Indication)”, as applicable.